Cargando…
Drug Antagonism and Single Agent Dominance Result from Differences in Death Kinetics
Cancer treatment generally involves drugs used in combinations. Most prior work has focused on identifying and understanding synergistic drug-drug interactions; however, understanding antagonistic interactions remains an important and understudied issue. To enrich for antagonism and reveal common fe...
Autores principales: | Richards, Ryan, Schwartz, Hannah R., Honeywell, Megan E., Stewart, Mariah S., Cruz-Gordillo, Peter, Joyce, Anna J., Landry, Benjamin D., Lee, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311243/ https://www.ncbi.nlm.nih.gov/pubmed/32251407 http://dx.doi.org/10.1038/s41589-020-0510-4 |
Ejemplares similares
-
FLICK: an optimized plate reader-based assay to infer cell death kinetics
por: Richards, Ryan, et al.
Publicado: (2021) -
Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
por: Landry, Benjamin D, et al.
Publicado: (2018) -
Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response Profiles
por: Schwartz, Hannah R., et al.
Publicado: (2020) -
Antagonism of Therapeutic Agents
Publicado: (1878) -
p53 controls choice between apoptotic and non-apoptotic death following DNA damage
por: Honeywell, Megan E., et al.
Publicado: (2023)